Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SPRO Spero Therapeutics > Detailed Quotes

SPRO Spero Therapeutics

1.950
-0.070-3.47%
Trading Session 09/28 12:20 ET
High
1.955
Open
1.890
Turnover
5.28M
Low
1.810
Pre Close
2.020
Volume
2.79M
Market Cap
68.38M
P/E(TTM)
Loss
52wk High
18.840
Shares
35.07M
P/E(Static)
Loss
52wk Low
0.680
Float Cap
47.21M
Bid/Ask %
26.83%
Historical High
23.639
Shs Float
24.21M
Volume Ratio
0.11
Historical Low
0.680
Dividend TTM
--
Div Yield TTM
--
P/B
1.90
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
11.52%
Amplitude
7.18%
Avg Price
1.894
Lot Size
1
Float Cap
47.21M
Bid/Ask %
26.83%
Historical High
23.639
Shs Float
24.21M
Volume Ratio
0.11
Historical Low
0.680
Dividend TTM
--
P/B
1.90
Dividend LFY
--
Turnover Ratio
11.52%
Amplitude
7.18%
Avg Price
1.894
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
CEO: Dr. Ankit Mahadevia, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...